Injection solutions to treat neuropathic symptoms and other sensorimotor disorders that are due to neuromas of the foot or other entrapment neuropathies of peripheral nerves, and method of use
First Claim
Patent Images
1. A medication comprising about 45 ccs of 0.5% bupivacaine hydrochloride, about 2 ccs of methylprednisolone acetate sterile aqueous suspension 80 mg/cc;
- about 1 cc of Dexamethasone Sodium Phosphate 4 mg/cc; and
about 2 ccs of 1% absolute alcohol for a total of about 50 ccs of medication.
0 Assignments
0 Petitions
Accused Products
Abstract
Injection solutions to treat nerve disorders of the foot are disclosed. A method of treatment is also disclosed
-
Citations
14 Claims
-
1. A medication comprising about 45 ccs of 0.5% bupivacaine hydrochloride, about 2 ccs of methylprednisolone acetate sterile aqueous suspension 80 mg/cc;
- about 1 cc of Dexamethasone Sodium Phosphate 4 mg/cc; and
about 2 ccs of 1% absolute alcohol for a total of about 50 ccs of medication. - View Dependent Claims (2)
- about 1 cc of Dexamethasone Sodium Phosphate 4 mg/cc; and
-
3. A method of medically treating a neuropathology, comprising the steps of injecting about 1 cc of a medication into an inter metatarsal, neuropathological space, the medication comprising about 45 ccs of 0.5% bupivacaine hydrochloride;
- about 2 ccs of methylprednisolone acetate sterile aqueous suspension 80 mg/cc;
about 1 cc Dexamethosone Sodium Phosphate 4 mg/cc; and
about 2 cc of 1% absolute alcohol. - View Dependent Claims (4, 5)
- about 2 ccs of methylprednisolone acetate sterile aqueous suspension 80 mg/cc;
-
6. A medication comprising about 45 ccs of one or both of the materials selected from the group consisting of bupivacaine hydrochloride and lidocaine hydrochloride;
- about 2 ccs of methylprednisolone acetate sterile aqueous suspension 80 mg/cc;
about icc of Dexamethosone Sodium Phosphate 4 mg/cc; and
about 2 ccs of 1% absolute alcohol. - View Dependent Claims (7, 14)
- about 2 ccs of methylprednisolone acetate sterile aqueous suspension 80 mg/cc;
-
8. A medication comprising about 90% by volume of 0.5% bupivacaine hydrochloride, about 4% by volume of methylprednisolone acetate sterile aqueous suspension 80 mg/cc;
- about 2% by volume of Dexamethasone Sodium Phosphate 4 mg/cc; and
about 4% by volume of 1% absolute alcohol. - View Dependent Claims (9)
- about 2% by volume of Dexamethasone Sodium Phosphate 4 mg/cc; and
-
10. A method of medically treating a neuropathology, comprising the steps of injecting about icc of a medication into an inter metatarsal, neuropathological space, the medication comprising about 90% by volume of 0.5% bupivacaine hydrochloride;
- about 4% by volume of methylprednisolone acetate sterile aqueous suspension 80 mg/cc;
about 2% by volume Dexamethosone Sodium Phosphate 4 mg/cc; and
about 4% by volume of 1% absolute alcohol. - View Dependent Claims (11, 12)
- about 4% by volume of methylprednisolone acetate sterile aqueous suspension 80 mg/cc;
-
13. A medication comprising about 90% by volume of one or both of the materials selected from the group consisting of bupivacaine hydrochloride and lidocaine hydrochloride;
- about 4% by volume of methylprednisolone acetate sterile aqueous suspension 80 mg/cc;
about 2% by volume of Dexamethosone Sodium Phosphate 4 mg/cc; and
about 4% by volume of 1% absolute alcohol.
- about 4% by volume of methylprednisolone acetate sterile aqueous suspension 80 mg/cc;
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeCharles J. Gudas, Ludwig A. Lettau
-
Original AssigneeCharles J. Gudas, Ludwig A. Lettau
-
InventorsGudas, Charles J., Lettau, Ludwig A.
-
Application NumberUS10/412,933Publication NumberTime in Patent OfficeDaysField of SearchUS Class Current514/171CPC Class CodesA61K 2300/00 Mixtures or combinations of...A61K 31/137 Arylalkylamines, e.g. amphe...A61K 31/445 Non condensed piperidines, ...A61K 31/573 substituted in position 21,...
